Tsukasa Matsubara Selected Research

Tsukasa Matsubara Research Topics

Disease

38	Rheumatoid Arthritis 11/2022 - 08/2003
4	Infections 02/2022 - 01/2009
1	Herpes Zoster 04/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Necrosis 05/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2016
1	Glucose Intolerance 09/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2015
1	Type 2 Diabetes Mellitus (MODY) 09/2015
1	Hypersensitivity (Allergy) 03/2014
1	Acute Disease 01/2014
1	Symptom Flare Up 05/2013
1	Surgical Wound Infection 11/2011
1	Arthritis (Polyarthritis) 11/2011

Drug/Important Bio-Agent (IBA)

16	Methotrexate (Mexate)FDA LinkGeneric 06/2022 - 01/2005
11	Biological ProductsIBA 04/2022 - 01/2009
10	Abatacept (Orencia)FDA Link 04/2022 - 03/2013
8	Antirheumatic Agents (DMARD)IBA 06/2022 - 11/2011
6	Adalimumab (Humira)FDA Link 02/2022 - 11/2012
6	tocilizumab (atlizumab)FDA Link 05/2020 - 01/2009
4	GLPG0634IBA 04/2022 - 01/2022
3	Sulfasalazine (Azulfidine)FDA LinkGeneric 06/2022 - 02/2004
3	Certolizumab Pegol FDA Link 01/2021 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 10/2020 - 01/2009
2	AutoantigensIBA 01/2022 - 08/2003
2	Tumor Necrosis Factor InhibitorsIBA 10/2020 - 05/2020
2	Infliximab (Remicade)FDA Link 11/2019 - 11/2016
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2015
2	Biomarkers (Surrogate Marker)IBA 11/2016 - 09/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016 - 01/2009
2	bucillamine (SA 96)IBA 01/2016 - 01/2005
2	Peptides (Polypeptides)IBA 04/2015 - 08/2003
2	AntibodiesIBA 04/2015 - 03/2014
2	Monoclonal AntibodiesIBA 03/2014 - 01/2009
1	Interleukin-6 InhibitorsIBA 11/2022
1	iguratimodIBA 06/2022
1	Anti-Citrullinated Protein AntibodiesIBA 04/2022
1	omega-Chloroacetophenone (Mace)IBA 04/2022
1	golimumab FDA Link 05/2020
1	Biosimilar PharmaceuticalsIBA 11/2019
1	Etanercept (Enbrel)FDA Link 03/2017
1	Pharmaceutical PreparationsIBA 11/2016
1	isomaltulose (palatinose)IBA 09/2015
1	DextrinsIBA 09/2015
1	Glucose (Dextrose)FDA LinkGeneric 09/2015
1	Insulin (Novolin)FDA Link 09/2015
1	Therapeutic UsesIBA 01/2005
1	AcetyltransferasesIBA 02/2004
1	Protein-Arginine DeiminasesIBA 08/2003
1	AutoantibodiesIBA 08/2003
1	EnzymesIBA 08/2003

Therapy/Procedure

4	Therapeutics 08/2017 - 11/2012
2	Orthopedic Procedures 01/2020 - 11/2011
1	Retreatment 01/2014
1	Perioperative Period 05/2013
1	Operative Surgical Procedures 11/2011
1	Arthroplasty 11/2011